A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin?? in children with short stature born small for gestational age with no catch-up growth by 2 years of age or older
|Effective start/end date||4/19/19 → 4/30/24|
- NOVO NORDISK, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.